Homing of liposomes to target cells.

Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst (2009) 1.73

Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release (2010) 1.19

Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J Pharm Sci (2008) 1.07

Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy. Int J Nanomedicine (2012) 0.79

Use of liposomes in treating type II glycogenosis. Br Med J (1976) 0.79

Co-encapsulating the fusogenic peptide INF7 and molecular imaging probes in liposomes increases intracellular signal and probe retention. PLoS One (2015) 0.76

The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem (1971) 3.73

Liposomes as immunological adjuvants. Nature (1974) 2.37

The carrier potential of liposomes in biology and medicine (first of two parts). N Engl J Med (1976) 2.03

Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats. Biochem J (1972) 1.97

Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J (1980) 1.97

Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem (1972) 1.74

Drug entrapment in liposomes. FEBS Lett (1973) 1.73

Enzyme-containing liposomes alleviate a model for storage disease. Nature (1973) 1.63

Targeting of drugs. Nature (1977) 1.49

The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med (1976) 1.49

Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem (1970) 1.47

Homing of liposomes to target cells. Biochem Biophys Res Commun (1975) 1.46

Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci (1982) 1.40

Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta (1991) 1.37

Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats. Possible therapeutic applications. Eur J Biochem (1974) 1.28

Drug-carrier potential of liposomes in cancer chemotherapy. Lancet (1974) 1.24

Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23

Penetration of target areas in the rat by liposome-associated bleomycin, glucose oxidase and insulin. FEBS Lett (1976) 1.15

Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Biophys Res Commun (1979) 1.14

Targeting of drugs: implications in medicine. Lancet (1981) 1.13

Liposome-entrapped plasmid DNA: characterisation studies. Biochim Biophys Acta (2000) 1.09

Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology (1973) 1.08

Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol (1974) 1.08

The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett (1980) 1.08

Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine (2001) 1.07

Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine (1987) 1.06

Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen. FEBS Lett (1979) 1.06

Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. J Immunol (1989) 1.05

Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues. Life Sci (1977) 1.05

Decreased monoamine oxidase activity in liver of iron-deficient rats. Can J Biochem (1969) 1.03

Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response. Immunol Lett (1987) 1.03

Enzyme entrapment in liposomes. Methods Enzymol (1976) 1.03

Late postoperative results in males treated for testicular torsion during childhood. J Pediatr Surg (1994) 1.03

Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. Immunology (1987) 1.02

Liposomes as vehicles for the local release of drugs. Clin Sci Mol Med (1975) 1.01

Cholesterol content of small unilamellar liposomes controls phospholipid loss to high density lipoproteins in the presence of serum. FEBS Lett (1980) 1.00

Is half-life of circulating liposomes determined by changes in their permeability? FEBS Lett (1982) 1.00

Interaction of liposomes with blood plasma proteins. Biochem Soc Trans (1976) 0.98

Comparative effect and fate of non-entrapped and liposome-entrapped neuraminidase injected into rats. Biochem J (1974) 0.98

Mannose-mediated targeted immunoadjuvant action of liposomes. Immunology (1988) 0.96

Novel sorbitan monostearate organogels. J Pharm Sci (1999) 0.96

Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase. Lancet (1977) 0.95

Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta (1985) 0.95

Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival. Res Commun Chem Pathol Pharmacol (1975) 0.95

Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept. Ann N Y Acad Sci (1978) 0.94

Preparation of liposomes containing factor VIII for oral treatment of haemophilia. J Microencapsul (1989) 0.93

Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochim Biophys Acta (1997) 0.92

Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta (1996) 0.90

Plasma-induced release of solutes from small unilamellar liposomes is associated with pore formation in the bilayers. Biochem J (1981) 0.90

Tissue and hepatic subcellular distribution of liposomes containing bleomycin after intravenous administration to patients with neoplasms. Clin Sci Mol Med (1976) 0.89

Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. Lancet (1976) 0.89

Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target (1994) 0.89

The effect of the cholesterol content of small unilamellar liposomes on the fate of their lipid components in vitro. Life Sci (1980) 0.88

Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice. FEBS Lett (1974) 0.87

Tritiation of glycoproteins. Biochem Biophys Res Commun (1973) 0.86

Intracellular distribution of copper in the liver of the rat. Can J Biochem (1967) 0.85

Interaction of a nonionic surfactant-based organogel with aqueous media. Int J Pharm (1999) 0.85

Water-in-sorbitan monostearate organogels (water-in-oil gels). J Pharm Sci (1999) 0.85

Fate of a liposome-associated agent injected into normal and tumour-bearing rodents: attempts to improve localization in tumour tissues [proceedings]. Biochem Soc Trans (1977) 0.85

Liposomes in the therapy of lysosomal storage diseases. Nature (1978) 0.85

Targeting of liposomes to accessible cells in vivo. Ann N Y Acad Sci (1985) 0.84

The use of monoclonal anti-Thy1 IgG1 for the targeting of liposomes to AKR-A cells in vitro and in vivo. Biochim Biophys Acta (1984) 0.84

Tumour regression with liposome-entrapped asparaginase: some immunological advantages. Biochem Soc Trans (1976) 0.84

Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Biochem J (1971) 0.84

Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection. Hepatology (1998) 0.84

Penetration of target areas in the rat by liposome-associated agents administered parenterally and intragastrically. Biochem Soc Trans (1976) 0.84

Formation of hybrid liposomes from negatively and positively charged liposomes: a possible model for the study of membrane fusion. Biochem Soc Trans (1978) 0.83

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice. Vaccine (1993) 0.83

Vaccines: recent trends and progress. Immunol Today (1990) 0.83

Old drugs in new clothing. Nature (1984) 0.82

Rapid partial purification of placental glucocerebroside beta-glucosidase and its entrapment in liposomes. Biochem J (1977) 0.82

Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively. Biochem J (1981) 0.81

Hepatitis-B-surface-antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen [proceedings]. Biochem Soc Trans (1979) 0.81

Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats. Biochim Biophys Acta (1996) 0.81

Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators. Immunology (1989) 0.81

Tailoring liposome structure. Nature (1980) 0.81

Synthesis, characterization and properties of sialylated catalase. Biochim Biophys Acta (1996) 0.81

Toxicity of sphingomyelin-containing liposomes after chronic injection into mice. Br J Exp Pathol (1983) 0.81

Interaction of antibody-bearing small unilamellar liposomes with target free antigen in vitro and in vivo. Some influencing factors. Biochem J (1981) 0.81

Preparation of glucocerebroside beta-glucosidase for entrapment in liposomes and treatment of patients with adult Gaucher's disease. Biochem Soc Trans (1976) 0.81

Antibody-coated liposomes. The role of non-specific antibody adsorption. FEBS Lett (1986) 0.81

Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives. J Pharm Biomed Anal (1997) 0.81

The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. Int J Pharm (2001) 0.80

Incorporation of hepatitis-B surface antigen (HBsAg) into liposomes. Biochem Soc Trans (1978) 0.80

Fate of cholesterol-rich liposomes after subcutaneous injection into rats. Biochim Biophys Acta (1983) 0.80

IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines. J Med Microbiol (1994) 0.80

Experiences after long-term treatment of a type I Gaucher disease patient with liposome-entrapped glucocerebroside: beta-glucosidase. Birth Defects Orig Artic Ser (1980) 0.80

Role of protein in removal of copper from the liver. Nature (1968) 0.80

Morphological observations on liposomes bearing covalently bound protein: studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques. Biochim Biophys Acta (1998) 0.80

Electron microscopic cytochemical localization of intravenously injected liposome-encapsulated horseradish peroxidase in rat liver cells. Adv Exp Med Biol (1976) 0.79

Liposomes as immunological adjuvants. Recent Results Cancer Res (1976) 0.78

Entrapment of mRNA and rRNA into large monolamellar liposomes derived from hybrid small monolamellar liposomes. Biochem Soc Trans (1978) 0.78

Dehydration-rehydration vesicle methodology facilitates a novel approach to antibody binding to liposomes. Biochim Biophys Acta (1989) 0.78

Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. Invest Radiol (1988) 0.78

Comparison of the immune response against polio peptides covalently-surface-linked to and internally-entrapped in liposomes. Asian Pac J Allergy Immunol (1991) 0.78

Entrapment of haemoglobin into liposomes by the dehydration-rehydration method: vesicle characterization and in vivo behaviour. Biochim Biophys Acta (1994) 0.78

Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens? Eur J Pharm Sci (1999) 0.77

A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: potential uses in drug and vaccine delivery. J Drug Target (1995) 0.77

The effect of lipid composition on the stability of liposomes in vivo [proceedings]. Biochem Soc Trans (1979) 0.77

Stability and clearance of small unilamellar liposomes. Studies with normal and lipoprotein-deficient mice. Biochim Biophys Acta (1983) 0.77